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Background: Carbonic anhydrases (CA) catalyze the inter-conversion of CO2 with HCO3 and H+, and are in-
volved in a wide variety of physiologic processes such as anion transport, pH regulation, and water balance.
In mammals there are sixteen members of the classical α-type CA family, while the simple genetic model or-
ganism Caenorhabditis elegans codes for six αCA isoforms (cah-1 through cah-6).
Methods: Fluorescent reporter constructs were used to analyze gene promoter usage, splice variation, and protein
localization in transgenic worms. Catalytic activity of recombinant CA proteins was assessed using Hansson's
histochemistry. CA's ability to regulate pH as a function of CO2 and HCO3wasmeasured using dynamic ﬂuorescent
imaging of genetically-targeted biosensors.
Results: Each of the six CA genes was found to be expressed in a distinct repertoire of cell types. Surprisingly,
worms also expressed a catalytically-active CA splice variant, cah-4a, in which an alternative ﬁrst exon targeted
the protein to the nucleus. Cah-4a expression was restricted mainly to the nervous system, where it was found
in nearly all neurons, and recombinant CAH-4A protein could regulate pH in the nucleus.
Conclusions: In addition to establishing C. elegans as a platform for studying αCA function, this is the ﬁrst example
of a nuclear-targeted αCA in any organism to date.
General signiﬁcance: A classical αCA isoform is targeted exclusively to the nucleus where its activity may impact
nuclear physiologic and pathophysiologic responses.© 2012 Elsevier B.V. All rights reserved.1. Introduction
Carbonic anhydrases (CA, E.C. 4.2.1.1) are zinc-containing metal-
loenzymes (except for the ζ form, which utilizes cadmium instead)
that catalyze the reversible hydration of carbon dioxide (CO2) to
bicarbonate ions (HCO3−) and protons (H+). CA's are divided
into several distinct classes (α, β (which likely includes the class
previously categorized as ε),γ, δ and ζ), ofwhichmammalian CAs belong
to theα-class. To date, sixteen CA genes have been identiﬁed in humans,
with isozymes distributed between the cytoplasm (CAI, II, III, VII, and
XIII), the cell membrane (CAIV, IX, XII, and XIV), the mitochondria
(CAVa and CAVb), and the extracellular space (CAVI) [1,2]. The CAXV
gene is expressed in rodents, but appears to have become a pseudogene
in primates [3]. Although most of the human CAs are catalytic, at leastserum albumin; CA, carbonic
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l rights reserved.three of them (CAVIII, CAX, and CAXI) are not. Catalytic CA enzymes
have two conserved features, a Zn2+ ion linked to a histidine triad
through imidazoles [2] and a fourth histidine acting as a proton shuttle
[4]. Gene products that are acatalytic appear to lack one or more of
these features.
In animals, CAs participate in pH homeostasis, CO2 and bicarbonate
transport, water and electrolyte balance, and biosynthetic reactions;
the precise role of individual CA isozymes is determined by their cellular
and tissue expression, subcellular localization, and catalytic rate [5]. For
example, mammalian CAII is an intracellular protein that is widely
expressed, it has a fast rate of catalysis that has been deemed
diffusion-limited, and its role in transport metabolons that link CA ac-
tivity to HCO3− transporters has been suggested to maximize HCO3−
membrane transport processes [6–10]. As such, it is not surprising
that mutations in CAII have been linked to a variety of disorders includ-
ing osteopetrosis, renal tubular acidosis and cerebral calciﬁcation [11].
In contrast, the expression of the GPI-anchored CAIV isozyme on the
cell surface is thought to help buffer the extracellular space in the brains
of mice [12] and CAIV has been shown to interact functionally with AE3
to mediate Cl−/HCO3− exchange [13]. It is possible that this regulation of
extracellular pHmay contribute to synaptic excitability [14,15]. However,
it is equally possible that a non-catalytic function of CAIVmay contribute
to its physiologic role in select cells, as recent data have suggested that
the transport activity of the high-afﬁnity monocarboxylate transporter
MCT2 is enhanced by CAIV independent of the latter's catalytic activity
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types, thus far CAIVmutational phenotypes have been limited to the ret-
ina [17].
In addition to their normal physiologic functions, alterations in CA
expression have been correlated with pathologic conditions. For ex-
ample, CAIX is regulated by hypoxia-inducible factor, hypoxia is a
hallmark of many cancers, and CAIX has been shown to be elevated
in many tumor types [18,19]. In fact, CAIX antibodies are useful as a
diagnostic marker for tumors [20–23] and CAIX inhibition is currently
being explored as a therapeutic strategy for cancer [24]. Similarly, ac-
etazolamide, a classic CA inhibitor, is used to treat various diseases/
disorders, including glaucoma [25], epileptic seizures [26], brain
swelling following surgery [27], and altitude sickness [28].
Although CAs are widely studied, our understanding of them re-
mains veiled. One of the most obvious gaps is a lack of knowledge as
to the normal physiologic role of the acatalytic isoforms. The genome
of the model organism Caenorhabditis elegans codes for six α-CA iso-
forms (cah-1, 2, 3, 4, 5 and 6), and three of these lack the necessary com-
ponents for catalytic activity (cah-1, 2 and 6). Thus, C. elegansmay be a
useful reductionist model for discerning the function of both catalytic
CAs as well as the evolutionarily conserved acatalytic proteins. Previ-
ously, the temporal expression patterns of the worm CA gene family
have been studied [29] and one of these genes, cah-4, has been shown
to be regulated by both environmental pH [30] and oxygen levels [31].
Cah-4 may also play a role in the progression of muscle degeneration
in a worm model of muscular dystrophy [32].
Here, we experimentally deﬁned the transcripts arising from the
six cah genes in worms, including their usage of alternative pro-
moters and splice variation. We generated transgenic nematodes to
determine the gene expression patterns and intracellular location of
the six worm cah gene products, as well as how splice variation af-
fected protein targeting. In addition, we expressed the C. elegans cah
cDNAs and their splice variants in mammalian tissue culture cells,
then assessed protein localization and activity, respectively.
To our surprise, we found a splice variant of cah-4, the same gene
implicated by three separate groups as being physiologically important
[30–32], that was targeted to the cell nucleus. Nuclear expression,
which required a 45 amino acid N-terminal extension coded for by an
alternative ﬁrst exon, occurred nearly exclusively and ubiquitously
throughout the nervous system. Though an RNA splicing factor has pre-
viously been shown to have catalytic CA activity [33], our results are the
ﬁrst to demonstrate that a classicalαCA resides in the nucleus of any or-
ganism. Both of the cah-4 splice variants were found to be catalytically
active, and we hypothesize that CAH-4A may contribute to nuclear pH
regulation or oxidative stress resistance.
In conclusion, the results presented here form a foundation upon
which to structure genetic approaches using a powerful model system
to identify new functions for a widespread, evolutionarily-conserved
gene family.2. Methods
2.1. C. elegans strains
Nematodes were routinely cultured at either 16 °C or 20 °C on
Normal Growth Media agar plates seeded with OP50 bacteria. To cre-
ate transgenic lines, young adult worms (generally pha-1(e2123ts)III
mutants) grown at the permissive temperature of 16 °C were microin-
jected with DNA at a ﬁnal concentration of 150 ng/μl in high-potassium
injection buffer [34]. In general, equal amounts of experimental DNA
and rescue marker (pCL1, a vector coding for pha-1) were co-injected.
In some cases, over-expression of GFP-tagged CA was toxic to worms,
and in these cases the amount of experimental DNA in the injection
mix was reduced.
The strains developed and reported on in this work are:Transcriptional fusions (referred to in the ﬁgures as Pgenename::
GFP) — KWN333, pha-1(e2123ts)III rnyEx199 [Pcah-1::GFP PCR;
pCL1 (pha-1+)]; KWN334, pha-1(e2123ts)III rnyEx200 [Pcah-2a::
GFP PCR; pCL1 (pha-1+)]; KWN335, pha-1(e2123ts)III rnyEx201
[Pcah-2b::GFP PCR; pCL1 (pha-1+)]; KWN336, pha-1(e2123ts)III
rnyEx202 [Pcah-3::GFP PCR; pCL1 (pha-1+)]; KWN337, pha-1(e2123ts)
III rnyEx203 [Pcah-5::GFP PCR; pCL1 (pha-1+)]; KWN338, pha-
1(e2123ts)III rnyEx204 [Pcah-6::GFP PCR; pCL1 (pha-1+)].
Translational fusions (referred to in the ﬁgures as Pgenename::PRO-
TEIN::GFP) — KWN339, pha-1(e2123ts)III him-5(e1490)V, rnyEx205
[Pcah-5::CAH-5::pHluorin PCR; pCL1 (pha-1+)]; KWN340, pha-
1(e2123ts)III him-5(e1490)V, rnyEx206 [Pcah-3::CAH-3::GFP PCR;
pCL1 (pha-1+)]; KWN348, pha-1(e2123ts)III him-5(e1490)V,
rnyEx213 [Pcah-1::CAH-1::GFP PCR; pCL1 (pha-1+)]; KWN349, pha-
1(e2123ts)III him-5(e1490)V, rnyEx211 [Pcah-2b::CAH-2B::GFP PCR;
pCL1 (pha-1+)]; KWN350, pha-1(e2123ts)III him-5(e1490)V,
rnyEx214 [Pcah-6::CAH-6::GFP PCR; pCL1 (pha-1+)]; KWN351,
pha-1(e2123ts)III him-5(e1490)V, rnyEx215 [Pcah-2a::CAH-2A::
GFP PCR; pCL1 (pha-1+)].
Cah-4 fusions: KWN172, pha-1(e2123ts)III him-5(e1490)V, rnyEx096
[Pcah-4a::GFP PCR; pCL1 (pha-1+)]; KWN35, pha-1(e2123ts)III
him-5(e1490)V rnyEx013 [pIA3-R01a (Pcah-4a::CAH-4A::GFP), pCL1
(pha-1+)]; KWN36, pha-1(e2123ts)III him-5(e1490)V rnyEx014
[pIA3-R01b (Pcah-4b::CAH-4B::GFP), pCL1 (pha-1+)]; KWN377, pha-
1(e2123ts)III rnyEx232 [Pcah-4a::GFP::CAH-4A PCR, pCL1 (pha-1+)];
KWN378, pha-1(e2123ts)III rnyEx233 [pKT23 (Pnhx-2::CAH-4A exon 1::
GFP), pCL1 (pha-1+)].
2.2. Molecular techniques
2.2.1. 5′ and 3′ RACE
Random hexamer primers were used to synthesize cDNA from a
mixed-stage population of C. elegansusing an iScript TmcDNAsynthesis
kit (BioRad, Hercules, CA). Nested gene-speciﬁc oligonucleotides were
then employed in consecutive rounds of PCR in combination with an
adaptor primer for 3′ RACE or SL1/SL2 leader primers for 5′ RACE
(almost all C. elegans mRNAs have a non-template encoded 5′
trans-spliced 22 nt leader added post-transcriptionally, with SL2
leaders being good indicators of the ~15% ofwormgenes that are down-
stream in an operon). Each individual PCR product was gel-isolated,
cloned, and sequenced.
2.2.2. cDNA expression and detection
The predicted ORFs for each cah gene product were cloned from
gel-isolated PCR fragments into the vector pcDNA3.1-V5/His/topo
(Invitrogen, Carlsbad, CA) to create pcDNA3.1cah-1 through
pcDNA3.1cah-6. Each insert was fully sequenced on both strands
and was engineered to lack the endogenous stop codon. Instead, a
V5 epitope was encoded in-frame at the C-terminus of each ORF;
this epitope was recognized by a commercially available mouse
monoclonal anti-V5 antibody (Invitrogen). CHO cells that had been
transiently transfected with the cah expression vectors were ﬁxed
in PBS/2% paraformaldehyde/50% methanol for 20 min at 4 °C, then
permeabilized and blocked in PBS/0.1% Triton X-100/5% BSA/1% Normal
Goat Serum for 1 h at RT prior to antibody incubation (1:2000 dilution
in blocking buffer). Following 3× washes in PBS/0.1% Triton X-100,
the anti-V5 antibody was detected using a 1:5000 dilution of rabbit
anti-mouse IgG conjugated to Alexa Fluor 488.
The rabbit CAIV expression vector was a kind gift of Dr. George
Schwartz (Univ. of Rochester).
2.2.3. GFP fusions
In order to create transcriptional and translational fusions of the
cah promoters and genomic ORFs to GFP for expression in transgenic
worms, PCR sewing was used. In short, a PCR product ampliﬁed from
C. elegans genomic DNA was engineered with a non-template
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it was complementary to the 5′ end of a separate PCR product coding
for GFP (with the unc-54 3′ UTR added for mRNA stability). The two
PCR products were gel-isolated, combined, and allowed to progress
through ﬁve rounds of PCR ampliﬁcation in the absence of primers,
resulting in the annealing and extension of the two products. Prior
to the sixth round of ampliﬁcation, a 5′ nested primer targeted at
the promoter::ORF product and a 3′ nested primer targeted at the
unc-54 3′ UTR product were added and the reaction was allowed to
progress for an additional 20 cycles. The ﬁnal full length product
was phenol/chloroform extracted, precipitated with ethanol, and
used for microinjection. The sizes of the promoter fragments used
to drive expression in the PCR fusions were: cah-1, 3470 nt; cah-2a,
1399 nt; cah-2b, 1610 nt; cah-3, 3319 nt; cah-4a, 348 nt; cah-4b,
3286 nt; cah-5, 3056 nt; cah-6, 3531 nt.
2.2.4. Cah-4 vectors
Standardmolecular cloning techniqueswere used. The vector pKT23
(Pnhx-2::CAH-4AEXON1::GFP)was created by PCR ampliﬁcation of the
45 amino acid coding region found in the ﬁrst exon of cah-4a using
Acc65I-tagged primers, followed by digestion and cloning into the
Acc65I site of pIA5-nhx-2 [35]. The vectors pIA3-RO1a and pIA3-RO1b
were likewise created by PCR, using C. elegans genomic DNA as a tem-
plate. pIA3-RO1a contains a region from immediately downstream of
the ﬁrst (non-coding) exon in cah-4b to the end of the cah-4 coding
region, cloned in frame with GFP in the base vector pIA3 [35] as an
NheI-SacII fragment. pIA3-R01b contains the cah-4b promoter cloned
as an NheI-SacII fragment into pIA3, with the cah-4b coding region
then cloned as a SacII fragment into the resulting vector. This effec-
tively removed the cah-4a promoter and ﬁrst exon from the
construct.
2.2.5. NLS-pHluorin vector
pKT18 was created by PCR cloning the ratiometric ﬂuorescent bio-
sensor pHluorin cDNA [36] ampliﬁed using a primer containing a 5′
non-template encoded SV40 NLS into the topo TA cloning vector
pcDNA3.1 V5/His/topo (Invitrogen Corp., Carlsbad, CA). The insert
was fully sequence on both strands.
2.3. Dynamic ﬂuorescent imaging
pKT18 was transiently transfected into CHO cells in culture using
Lipofectamine 2000 (Invitroge., Carlsbad, CA) as recommended by
the manufacturer. Immediately following transfection, cells were
trypsinized onto glass coverslips and allowed to adhere under normal
growth conditions overnight. The following day, a coverslip contain-
ing adherent cells was placed into a perfusion chamber residing on
the stage of a Nikon Eclipse 2000 inverted microscope (Nikon Instru-
ments Inc., Melville, NY) equipped with a monochromator (TILL Pho-
tonics, Germany) and Cooke sensicam (Cooke Corp., Romuslus, MI)
running TILLvisION software for image acquisition. The cells were
superfused with buffer containing HCO3− (in mM): 115 NaCl, 20
NaHCO3−, 5.4 KCl, 0.4 KH2PO4, 0.33 NaH2PO4, 10 glucose, 20 Hepes,
1.2 CaCl2, 0.8 MgSO4, bubbled with 5% CO2 and adjusted to pH 7.4
with Tris. Following equilibration, the cells were switched to a
HCO3− free buffer (in mM): 135 NaCl, 5.4 KCl, 0.4 KH2PO4, 0.33
NaH2PO4, 10 glucose, 20 Hepes, 1.2 CaCl2, 0.8 MgSO4, pH adjusted to
7.4 with Tris base. During this period, 535-nM emissions were mea-
sured following excitation at either 410-nm or 470-nm, and the
ratio of these emissions was converted to pH by in situ calibration
using the high K+/nigericin technique [37].
2.4. Hansson's technique
CHO cells were plated onto glass coverslips and transiently trans-
fected with pcDNA3.1-based mammalian expression vectors codingfor V5 epitope-tagged CAH proteins using Lipofectamine 2000 (Invi-
trogen). 24-hours post-transfection, the cells were ﬁxed and stained
for CA activity using a cobalt–phosphate detection method [38]. Brieﬂy,
the cells were incubated overnight at 4 °C in 3% glutaraldehyde in 0.1 M
sodium phosphate buffer pH 7.3 to ﬁx. Following three rinses with
0.1 M sodium phosphate buffer (pH 7.3), the cells were incubated for
5 min in a solution made by combining 17 ml of solution A (containing
1 ml of 0.1 M CoSO4, 6 ml of 0.5 M H2SO4 and 10 ml of 0.066 M
KH2PO4) with 40 ml of solution B (0.75 g of NaHCO3 in 40 ml of
ddH2O). Each of these solutionswas prepared fresh from stocks as indi-
cated. The cells were then rinsed in 0.1 M sodium phosphate buffer (pH
7.3), and incubated in freshly-made 0.5% (NH4)2S for 2 min. The reac-
tion was halted by rinsing with ddH2O. To control for non-enzymatic
CA activity, the cells were pre-incubated in 10−4 M acetazolamide for
2 h.
3. Results
3.1. The cah family in worms
An in silico analysis based upon conserved regions from the mam-
malian αCA family indicated that the C. elegans genome contains the
coding potential for six αCA isoforms. 5′ and 3′ Rapid Ampliﬁcation of
cDNA Ends (RACE) was used to experimentally determine the prod-
ucts arising from transcription of these six putative genes. Two
rounds of RACE were performed using nested gene-speciﬁc primers
designed based upon the predicted DNA sequences in well-
conserved regions of the putative ORFs. 3′ RACE products were ampli-
ﬁed using an adaptor primer that was tagged onto the dT18 primer
used during cDNA synthesis, while 5′ RACE products were ampliﬁed
using upstream primers corresponding to either SL1 or SL2 trans-
spliced leader sequences, which are 22 nucleotide RNAs that are
added post-transcriptionally to most genes in worms. All of the
major products arising from these reactions were puriﬁed, cloned, se-
quenced and aligned to a genomic map to determine transcriptional
start sites and splice variation.
A schematic of our results, including the exons (shown in black),
5′ and 3′ UTR regions (shown in gray), and leader sequences (SL1)
is drawn to scale (in kb) in Fig. 1A. As indicated, each of the six cah
gene products was found to be trans-spliced to an SL1 leader, and
there was no evidence of SL2 splicing (data not shown). SL2 leaders
are generally restricted to the b15% of transcripts in worms that
occur in operons. As is often the case with worm transcripts, each of
the genes contained very short 5′ UTRs, while the 3′ UTRs were of
varying length. In addition, two splice variants were identiﬁed for
the cah-2 and cah-4 genes. This variation occurred at the 5′ ends
and resulted in alternative ﬁrst exons. For both cah-2 and cah-4, tran-
scription of the downstream splice variant was driven by a promoter
contained within the ﬁrst intron of the upstream splice variant, as in-
dicated (Fig. 1A).
Protein sequences were determined by virtual translation of the cah
ORFs, which were then aligned to the CA isozymes frommammals. The
slanted cladogram in Fig. 1B indicates the relatedness between the six
cah αCAs from C. elegans and CAI through CAXIV from humans (with
CAXV being a pseudogene). Interestingly, the CAs cluster into three dis-
tinct groups. These include soluble isozymes,membrane-associated iso-
zymes, and acatalytic isozymes. Cah-1, cah-2, and cah-6 are found in a
clade with the acatalytic isozymes, which is not unexpected given
their lack of certain residues necessary for catalytic activity. Cah-3
and cah-5 are most closely associated with the soluble, catalytic
human isozymes. Cah-4 is more closely related to the catalytic isozymes.
Not surprisingly given the expansion of the CA gene family in mammals,
the cladogram in Fig. 1B does not predict direct orthologs and the closest
relationship between the C. elegans and human CAs are found amongst
the acatalytic isozymes. There is little known as to themolecular function
of this sub-class of CA isozyme in mammals, but the intriguing
Fig. 1. The C. elegans genome codes for six alpha carbonic anhydrase isoforms. (A)
Schematic of the experimentally-deﬁned intron-exon structures for six cah genes,
drawn to scale (in kb). Coding exons are shown in black, while 5′ and 3′ UTRs are
shown in gray. SL1 leader trans-splice sites are as indicated. The promoter regions
used to determine expression patterns for each isoform and splice variant are denoted
by arrows. (B) Slanted cladogram indicating the relatedness between the six cah alpha
carbonic anhydrase gene products from C. elegans and representative CA isoforms from
humans. The outgroup-rootedmapwas generated usingUPGMA tree buildingwith Poisson
distance correction, running in bootstrap mode. Each of the six nematode carbonic anhy-
drases is highlighted by gray shadowing. Gene products that are clustered in the “acatalytic”
group (as well as CAVIII) lack a triad of histidines that is required formetal ion coordination
and activity.
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suggests an evolutionarily conserved and potentially important biologic
purpose.
3.2. Cellular expression patterns and intracellular location of the cah
gene products
To better understand the physiologic role of each of the six cah
gene products in worms, we determined where they were expressed.
Genomic PCR products containing the cah promoter regions were
used to drive the transcription of GFP in transgenic worms, and GFP
expression was assessed by ﬂuorescent microscopy. The genomic re-
gions used as promoters are denoted by arrows in Fig. 1A.
Neuronal expression was observed in all transgenic lines (Fig. 2).
In most cases only subsets of the 302 adult neurons expressed GFP,
but in at least two cases, cah-6 (Fig. 2) and cah-4a (Fig. 3D), expres-
sion appeared to occur throughout the entire nervous system. In ad-
dition to neuronal labeling, strong expression was observed in theintestine (Fig. 2; cah-2a, cah-3, and cah-5), the hypodermis (Figs. 2
and 3E; cah-4b and cah-5), and various muscle cells including the
vulva and pharynx (Figs. 2 and 3; cah-2a, cah-3, cah-4a, cah-4b, and
cah-5). A synopsis of these expression patterns can be found in
Table 1. This list is not inclusive, but does detail the major cell types
and organswhere expression of each isoformwas observed. Two caveats
are that promoter-driven GFP expression from transgenic extra-
chromosomal arrays only approximates endogenous gene expression,
and the expression of genes from arrays is suppressed in the C. elegans
germline.
In order to establish the intracellular residence of each CA iso-
zyme, the promoters and ORFs were fused to GFP in lieu of the endog-
enous stop codon by PCR sewing, and the PCR products were injected
into worms to create transgenic lines. Fluorescent images of these
lines conﬁrmed the cellular expression proﬁles established above,
and helped to clarify protein localization (Fig. S1; Table 1). One impor-
tant caveat here is that it is unclear whether these GFP fusion proteins
are functional, and as with all transgenic and fusion protein analysis,
the results need to be interpreted in this context.
Most of the isozymes that were predicted to be catalytic were
found in the cytoplasm (Fig. S1 and Fig. 3; cah-3, cah-4b, and cah-5).
Two of the putative acatalytic isozymes were intracellular but punc-
tate (Fig. S1; cah-1 and cah-2). These punca did not co-localize with
the mitochondrial label MitoTracker Red CMXRos and reducing the
concentration of the transgenes in the injectionmix by 1:30 gave sim-
ilar results, which led us to believe that they are not merely due to
non-speciﬁc protein aggregation (data not shown) The ﬁnal acatalytic
isozyme was associated with areas where neurons make contact with
other cells, including synapses and neuromuscular junctions (Fig. S1;
cah-6). We found no evidence for a mitochondrial CA such as mamma-
lian CAV, nor did we detect either extracellular or membrane-bound CA
inworms.While this is not a conclusive proof that such an isozymedoes
not exist, it is suggestive.
The most unexpected ﬁnding was the discovery of a nuclear CA
isozyme (Fig. 3; cah-4a). The cah-4 gene contains two alternative
ﬁrst exons whose expression is driven by distinct promoters
(Fig. 1). The only difference between the resulting proteins is a 45
amino acid region immediately following the initiator Met in
CAH-4A that is absent in CAH-4B. While a cah-4b translational fusion
protein was expressed most strongly in the excretory cell, GFP labeling
was also found in the cytoplasmof variousmuscle and hypodermal cells
(Fig. 3B). In contrast, the cah-4a promoter was expressed throughout
the nervous system as well as in the head muscle cells (Fig. 3D), and a
translational CAH-4A::GFP fusion protein was apparently directed to
the nucleus of these cells (Fig. 3F). In headmuscle cells, unlike neurons,
the nuclei are small compared to the overall cell size, and nuclear tar-
getingwas readily observable.We also conﬁrmed that GFPﬂuorescence
in neurons co-localized with DAPI staining in the nucleus (Fig. S2).
Moving GFP from the C-terminus to the N-terminus of CAH-4A
demonstrated that exon 1 was not strictly an N-terminal sorting signal
and that it could drive nuclear localization from a site within the fusion
protein (Fig. 4A). In fact, 45 amino acids coded for by exon 1 formed a
bonaﬁdeNLSwhich on its ownwas sufﬁcient to direct GFP to the nucle-
us (Fig. 4B). This targetingwas not limited to neurons, either, as an exon
1::GFP fusion that was driven by the nhx-2 promoter was found in the
nucleus of intestinal cells (Fig. 4C). Thus, we conclude that CAH-4A is
a nuclear CA, and we hypothesize that it contributes to neuronal func-
tion through a previously-unrecognized role in nuclear physiology.
3.3. Immunodetection and catalytic activity of recombinant CAs
To test for catalytic activity of the worm CAs, their ORFs were
cloned and expressed as recombinant V5 epitope-tagged proteins in
CHO cells. Anti-V5 antibody staining was used to assess recombinant
protein targeting, while Hansson's histochemistry was used to assay
catalytic activity. Hansson's stain is a cobalt precipitate that results
Fig. 2. Cah gene expression patterns. Representative confocal maximum projection images are shown of worms (L4-adult) from each of six transgenic strains expressing promoter::
GFP fusions corresponding to the genes indicated. A single DIC micrograph shows physiologic structure and the major organs are labeled. The white arrows indicate orientation
(a, anterior; p, posterior; d, dorsal; v, ventral). A summary of tissues where each cah promoter is active can be found in Table 1.
Fig. 3. Cah-4 codes for both cytoplasmic and nuclear carbonic anhydrase isoforms. Representative DIC (A–C) and ﬂuorescent maximum projection confocal micrographs (D–F) of
transgenic strains expressing promoter::ORF::GFP fusions, as indicated. Where possible, arrows have been used to indicate the relevant cells and cell groups. (A, D) The intra-exonic
cah-4a promoter drives GFP expression throughout the nervous system, as well as in head muscle cells. (B, E) The cah-4b promoter is active in a variety of tissues, including the
excretory cell, body wall muscle, hypodermis, seam cells, and the intestine, but is not expressed in neurons. These cells comprise most of the body architecture and are thus not
indicated by individual arrows. The CAH-4B::GFP fusion protein resides in the cytoplasm. (C, F) The CAH-4A::GFP fusion protein is targeted primarily to the nucleus, as is most readily
apparent in the head muscle cells. HMC, head muscle cell; DNC, dorsal nerve cord; EC, excretory cell; Hyp, hypodermal cells; Int, intestine; VNC, ventral nerve cord.
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Table 1
Expression patterns of cah isoforms.
Gene Cell type | localization
Cah-1 Neurons (++) | intracellular puncta
Cah-2a Neurons (+), Intestine | intracellular puncta
Cah-2b Neurons (+), vulva | intracellular puncta
Cah-3 Neurons (++), intestine, pharynx | cytoplasm
Cah-4a Neurons (+++), head muscle, vulval muscle | cytoplasm
Cah-4b Excretory cell, body wall muscle, intestine, hypodermis,
anal muscle | nucleus
Cah-5 Neurons (+), intestine, body wall muscle, hypodermis | cytoplasm
Cah-6 Neurons (+++) | synapses and neuromuscular junctions
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tential and the location of catalysis [38].
As a positive control, cells were transfected with rabbit CAIV, a
GPI-anchored extracellular CA that stains at cell–cell contacts when
reacted with Hansson's (Fig. 5D). As expected, despite being anti-V5
immuno-reactive, cells transfected with cah-1, cah-2 or cah-6 cDNAs
were not stained by Hansson's technique (data not shown). However,
cells transfected with cah-3, cah-4a or cah-4b cDNA were robustly
stained (Fig. 5E–G). In the case of cah-4a, the stainingwas predominantly
nuclear (Fig. 5G). This result also conﬁrmed previous data indicating that
the CAH-4B isozymewas catalytic [30]. Each of these three CA isozymes'
activities was inhibited by preincubation with 10 μM acetazolamide
(data not shown). Interestingly, we found that CAH-5, though expressed
in the cytoplasm, did not result in discernable CA activity usingHansson'sFig. 4. Exon 1 of cah-4a codes for a nuclear localization sequence. DIC/ﬂuorescent over-
lays of transgenic worms expressing various promoter::ORF::GFP conﬁgurations, as
follows: (A) The cah-4a promoter, with the GFP fused to the N-terminus of CAH-4A
rather than the C-terminus. (B) The cah-4a promoter, with the 45 amino acids coded
for by exon 1 of cah-4a fused to the N-terminus of GFP. (C) The intestine-speciﬁc
nhx-2 promoter, with exon 1 of cah-4a fused to GFP as above.technique (data not shown). This isozymemay have a very low catalytic
activity or speciﬁc requirements that are not met in this assay.
Cells that expressed either cah-3 or cah-4b cDNA were anti-V5 an-
tibody reactive in both the cytoplasm and the nucleus (Fig. 5A and B),
while cells that expressed cah-4a cDNA were reactive strictly in the
nucleus (Fig. 5C). We attribute the partial nuclear distribution of the
CAH-3 and CAH-4B proteins to the fact that they are quite small
(~30 kDa) and may passively diffuse through the nuclear pore, as
well as the fact that the nuclei in these cells are thicker than the cyto-
plasm, leading to what can appear to be nuclear enrichment when
viewed by epiﬂuorescent microscopy. GFP fusion proteins such as
shown in Fig. 2 are likely beyond the molecular weight range within
which free diffusion might occur. Even so, the results shown in
Fig. 4 are consistent with active targeting of CAH-4A to the nucleus,
as very little cytoplasmic signal was observed with either immuno-
detection or Hansson's staining.
3.4. CAH-4A inﬂuences HCO3- mediated changes in nuclear pH
CAs can contribute to pH regulation both inside and outside of the
cell. We next tested whether CAH-4A, consistent with its catalyticFig. 5. Recombinant carbonic anhydrase activity and protein localization in mammalian
tissue culture cells. (A–C) Fluorescent micrographs showing immunolocalization of V5
epitope-tagged CAH proteins expressed transiently in CHO cells (N, nuclei). (D–G)
Transmitted light images of CHO cells stained using Hansson's histochemistry to detect
carbonic anhydrase activity. Of the six cah genes tested, only the cah-3 and cah-4 gene
products had a catalytic rate sufﬁcient to observe reaction product. Rabbit CAIV served
as a positive control; CAIV is a GPI anchored protein whose activity is limited to the cell
periphery.
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pH was measured using dynamic ﬂuorescent imaging of the pH-
sensitive biosensor pHluorin, which was targeted to the nucleus via
an SV40 NLS. Cells were allowed to equilibrate in 20 mM HCO3−–5%
CO2-buffered solution. Following equilibration, washout of CO2 was
brought about by switching perfusion to nominally HCO3−–CO2-free
solution. This caused a rapid alkalinization whose rate was dependent
upon the conversion of HCO3− to CO2. Consistent with the results of
Hansson's staining, CHO cells expressing CAH-4A exhibited an in-
creased rate of alkalinization compared to control cells following
switchover (Fig. 6A). In addition, these cells exhibited an elevated
resting nuclear pH. Acetazolamide reduced the rate of pH change in
CAH-4A expressing cells to a value comparable to that of control
cells, but had little effect on the rate in control cells themselves
(Fig. 6B). We also found that expression of CAH-4B could accelerate
the rate of nuclear pH change, though to a lesser extent than CAH-4A,
consistent with its partial nuclear distribution in cultured cells (data
not shown). Towhat extent this is an overexpression artifact is currently
unknown. These results highlight the potential of a nuclear CA to contrib-
ute to organelle pH regulation. This abilitymay be particularly relevant in
response to changes in HCO3−–CO2 such as might result from cell metab-
olism or ischemic stress conditions.
4. Discussion
The mammalian CAs form a large family of zinc-containing metal-
loenzymes, and individual CAs have been shown to participate in pH
regulation, HCO3− and ion transport, water and electrolyte balance,
and photosynthesis and respiration [2,39,40]. As might be predicted,
CA gene expression and protein distribution contribute to their particu-
lar physiologic roles. For example, mitochondrial CAV in the liver fuels
pyruvate carboxylase and carbamoyl-phosphate synthetase, thus con-
tributing to gluconeogenesis and the urea cycle, respectively [41,42].
Similarly, salivary CAVI, the only secreted isozyme in this enzyme fam-
ily, is thought to help prevent dental plaque by reducing acidity in the
oral cavity [43,44]. Further, membrane-bound CAIV and XIV isozymes
contribute to extracellular pH buffering in the central nervous system
[12].
The three acatalytic CA isozymes CAVIII, CAX, and CAXI are quite
closely related to their active neighbors, and point mutations in the
coding regions have been shown to be sufﬁcient to convert a catalyt-
ically inactive protein to one with enzymatic CA activity [45,46]. How-
ever, very little is known about their physiologic function (for review,
see [1]). Several intriguing observations regarding CAVIII have been
reported:ﬁrst, like the catalytically active CA IX and XII isozymes, CAVIII
is overexpressed in certain cancers [47] and its expression can promoteFig. 6. CAH-4A accelerates pH changes that occur in the nucleus as a result of altering med
rescent imaging of a SV40 NLS-targeted pH biosensor (Miesenbock ref. [36]) in cells that h
(B) The initial rate of ΔpH following perfusion with HCO3−-free media was determined for s
cah-4+vehicle; ∇, cah-4+acetazolamide).cancer cell growth and invasiveness; second, CAVIII is present in
Purkinje cells, cerebellar nuclei and brainstem [48]; and third, a
Car8 mutant mouse (wdl) has a gait disorder and aberrant synaptic
morphology in the cerebellum [49]. Since CAVIII has been identiﬁed
as a binding partner for the inositol trisphosphate receptor and reg-
ulates its afﬁnity for substrate [50], it is possible that the phenotype
is related to calcium signaling in the cell.
Interestingly, in C. elegans three of the six αCA isozymes are pre-
dicted to be acatalytic based upon their lacking one or more of the
conserved histidines required for Zn2+ binding, and our observations
using Hannson's staining conﬁrm this prediction. This suggests that
CAs may have a conserved function independent of their role in CO2
metabolism. Large scale RNAi screens have failed to identify a phenotype
associated with the loss of any of these three isoforms, but the acatalytic
isozymes are expressed mainly in neurons (Table 1), and neurons are
typically refractory to RNAi. A more rigorous approach will involve
creating deletion alleles for the acatalytic CA genes. In this regard, a
strain containing a cah-1 deletion allele (ok2032) has been devel-
oped by the C. elegans Gene Knockout Consortium and is viable as a
homozygous null, but is presently uncharacterized.
In general, the cell expression patterns that we observed for the
worm CA genes (Fig. 2 and Table 1) were similar to those described
in a recent report [51]. However, our analysis of protein localization
using translational GFP fusions provided some additional details of in-
terest. First, based upon the distribution of the CA isozymes and the
lack of an overt mitochondrial leader sequence on any of the catalytic
variants, we conclude that worms lack a CAV ortholog. Second, the
acatalytic isozyme CAH-6 localized to regions of cell–cell contact, in-
cluding neuromuscular junctions (Fig. S1). While the ﬂuorescent res-
olution was insufﬁcient to determine whether the signal was
associated with vesicles inside the cell or the plasma membrane, the
pan-neural expression and speciﬁc targeting of this CA to synapses
suggest that it may play a role in neurotransmission. Given that
CAH-6 is one of the acatalytic isozymes, further dissection of its role
in neurons may help to shed light on this under-studied sub-class of
CAs. Finally, while it has been recognized that the cah-4 gene codes
for two alternate splice variants [30] whose expression is driven by
mutually exclusive promoters (Fig. 3), our results demonstrated
that this splicing generates a CA isozyme containing a 45 amino
acid N-terminal extension that is both necessary and sufﬁcient for
CAH-4A protein targeting to the cell nucleus (Fig. 4). This is the
ﬁrst example of a CA in any organism that resides in the nucleus,
and begs the question of what the physiologic role of a nuclear CA
might be.
While cah-4b is expressed in hypodermis, excretory cell andmuscle,
the cah-4a promoter drives expression throughout the nervous system,ia CO2 levels. (A) Representative traces of nuclear pH were obtained by dynamic ﬂuo-
ad been equilibrated in HCO3−/CO2 media as they were switched to HCO3−-free media.
ix separate trials under each of the conditions shown. (●, vehicle; ○, acetazolamide;▼,
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a potentially conserved function in these cells. Moreover, we and others
have shown that CAH-4 isozymes are catalytically active (Fig. 5 and
[29,30]). If catalytic activity is important for CAH-4A function, this
would suggest that the nucleus is capable of responding to changes in
HCO3−/CO2 metabolism. In fact, recombinant CAH-4A exhibited clear
nuclear activity when expressed in mammalian tissue culture cells
(Fig. 5), and was capable of regulating nuclear pH in response to ﬂuctu-
ations in HCO3−/CO2 (Fig. 6), asmight be predicted for a catalytic CA tar-
geted to the nucleus. It is unclear based solely upon this result however
whether CAH-4A plays a role in endogenous nuclear pH regulation and
similarly, how closely nuclear pH is tied to cytoplasmic pH. In fact,
nuclear pH regulation is a relatively unexplored topic in general. It is
likely that interrogating the physiologic role of CAH-4A in C. elegans
will provide insight to these questions. In this regard, a genetic deletion
of cah-4 has been annotated as being lethal in its homozygous state
(cah-4(tm2805)X; C. elegans Gene Knockout Consortium), clearly sug-
gesting an important function for at least one of the two cah-4 splice
variants. Furthermore, we have observed that overexpressing CAH-4A
in transgenicworms can lead to phenotypic abnormalities, including lo-
comotor defects (data not shown), though the molecular basis for this
dominant effect is currently unknown.
Interestingly, cah-4 expression has been shown to be increased by
hypoxia through the canonical HIF/VHL signaling pathway [31]. CAs
are commonly regarded as cytoprotective enzymes, and HIF respon-
sive genes generally promote survival under hypoxic conditions. For
example, both mammalian CAIX and CAXII have been shown to be
HIF responsive and are pro-survival factors. In particular, CAIX is
highly expressed in multiple cancers, where it is used as a tumor
marker. Mechanistically, CAIX is thought to facilitate acid diffusion
and acid transport, thus contributing to tumor pH regulation (for re-
view, see [52]). Moreover, a role for endogenous CAIX in neuronal
maintenance was demonstrated by morphological analysis showing
vacuolar degenerative changes in the brains of Car9−/− mice [53].
It has also been demonstrated that oxidative protein modiﬁcation
of CA isozymes, such as may occur under hypoxic conditions, is asso-
ciated with disease pathophysiology. For example, protein carbonyla-
tion of CAII correlates with neuronal pathology in Alzheimer's disease
[54] and carbonylation of CAIII contributes to oxidative deﬁciencies in
muscle [55].
However, despite these observations of parallel regulatory motifs
and the general underlying theme that CAs can modulate hypoxic
sensitivity, there are no clear mammalian CAH-4 orthologs. As regards
CAH-4A, none of the mammalian CAs has been shown to reside in the
cell nucleus, nor do any of them contain a canonical nuclear localization
signal. We suggest here that worm neurons are more exposed to envi-
ronmental insults than mammalian neurons and that endogenous pro-
tective mechanisms in worms may have evolved into adaptive
responses in mammals. This is consistent with the fact that worms are
incredibly hypoxic resistant compared to mammals. Thus in the ab-
sence of a canonical nuclear CA in mammals, it is worth considering
whether situational CA transport to the nucleus could occur, perhaps
in response to stress signaling. Alternatively, stressors might induce
the expression of a cryptic promoter or splice variant that encodes
a nuclear CA isozyme.
Though not of the classical αCA family, in fact there has been one
report of a protein capable of catalytic CA activity puriﬁed from the
nucleus of mammalian cells. The protein was identiﬁed as NonO/
p54nrb, and histochemical staining revealed CA activity in rat lympho-
cytes coincident with p54nrb expression [33]. p54nrb is associated
with PSF (polypyrimidine-tract-binding-protein-associated splicing fac-
tor) and has been reported to be involved in diverse nuclear processes
such as transcription, RNA processing, DNA unwinding and repair, and
may contribute to the progression ofmalignantmelanoma [56].Whether
CA activity contributes to any of these functions of p54nrb is currently
unknown.If a nuclear CA were catalytically active, our results suggest that it
could contribute to nuclear pH regulation, and we predict that this
might inﬂuence oxidative stress resistance. As alluded to above,
however, there is not much known about nuclear pH regulation.
Several reports have suggested that the pH of the nucleus is higher
than that of the surrounding cytoplasm [57,58], but how this might
occur mechanistically is unclear. Establishing a gradient between the
cytoplasm and the nucleus would require either a barrier to the diffu-
sion of protons or an extremely a fast enzyme that has H+ or OH− as
a reaction component. CAH-4B was shown to have a Kcat/Km of
5.4×107 M−1 s−1 [30], whichwhile not diffusion-limited is still second
only to that of mammalian CAII.
Compartmentalization could also help to establish a nuclear pH
microdomain. Although the nuclear pore should permit the free diffu-
sion of small molecules such as electrolytes, there is compelling evi-
dence that localized Ca2+ signaling within the nucleus occurs in
response to synaptic activity, and this signaling elicits subsequent
protectivemeasures [59]. Protection occurs through altering the neuron's
transcriptional proﬁle [60] and may involve morphologic changes in the
nucleus itself [61,62]. The observed alterations to nuclear geometry are
consistent with the idea that the nucleoplasm is restricted into signaling
microdomains. Since acid diffusion rates can be buffered by CA activity,
microdomainsmay contribute to the ability of CAH-4A to regulate pHho-
meostasis in the nucleus.
However, the pK of DNA, while affected by base composition, is gen-
erally quite low, and the negative charge on the phosphate backbone of
DNA will be largely unaffected by changes in pH in the physiologic
range, Thus, it is unlikely that small changes in nuclear pH will have
large effects on DNA binding to histones or transcription factors. It is
possible that there is an alternative mechanism whereby pH might
regulate nuclear function. Though pH is most commonly thought of
as providing a metabolic context that shapes enzymatic activities in
the cell, there is a growing notion that proton recognition may con-
tribute directly to cell signaling [63–66]. It will be fascinating to de-
termine whether CAH-4A contributes to nuclear pH homeostasis
and whether the loss of CAH-4A has functional consequences on
neuronal survival.
Acknowledgements
This work was supported in part by USPHS R01 NS064945 (K.N.)
and a UNCF/Merck Postdoctoral Fellowship Award to T.A.M. We also
acknowledge the C. elegans Genetics Center for strains.
Appendix A. Supplementary data
Supplementary data to this article can be found online at doi:10.
1016/j.bbamcr.2011.12.014.
References
[1] A. Aspatwar, M.E. Tolvanen, S. Parkkila, Phylogeny and expression of carbonic
anhydrase-related proteins, BMC Mol. Biol. 11 (2010) 25.
[2] W.S. Sly, P.Y. Hu, Human carbonic anhydrases and carbonic anhydrase deﬁciencies,
Annu. Rev. Biochem. 64 (1995) 375–401.
[3] S. Saari, M. Hilvo, P. Pan, G. Gros, N. Hanke, A. Waheed, W.S. Sly, S. Parkkila, The
most recently discovered carbonic anhydrase, CA XV, is expressed in the thick as-
cending limb of Henle and in the collecting ducts of mouse kidney, PLoS One 5
(2010) e9624.
[4] M. Schultz, W. Jin, A. Waheed, B.R. Moed, W. Sly, Z. Zhang, Expression proﬁle of
carbonic anhydrases in articular cartilage, Histochem. Cell Biol. 136 (2011)
145–151.
[5] C.T. Supuran, Carbonic anhydrases—an overview, Curr. Pharm. Des. 14 (2008)
603–614.
[6] D. Sterling, B.V. Alvarez, J.R. Casey, The extracellular component of a transport
metabolon. Extracellular loop 4 of the human AE1 Cl−/HCO3− exchanger binds
carbonic anhydrase IV, J. Biol. Chem. 277 (2002) 25239–25246.
[7] F.B. Loiselle, P.E. Morgan, B.V. Alvarez, J.R. Casey, Regulation of the human NBC3
Na+/HCO3− cotransporter by carbonic anhydrase II and PKA, Am. J. Physiol.
Cell Physiol. 286 (2004) C1423–C1433.
816 T.A. Sherman et al. / Biochimica et Biophysica Acta 1823 (2012) 808–817[8] P.E. Morgan, C.T. Supuran, J.R. Casey, Carbonic anhydrase inhibitors that directly
inhibit anion transport by the human Cl−/HCO3− exchanger, AE1, Mol. Membr.
Biol. 21 (2004) 423–433.
[9] B.V. Alvarez, G.L. Vilas, J.R. Casey,Metabolon disruption: a mechanism that regulates
bicarbonate transport, EMBO J. 24 (2005) 2499–2511.
[10] P.E. Morgan, S. Pastorekova, A.K. Stuart-Tilley, S.L. Alper, J.R. Casey, Interactions of
transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters, Am. J.
Physiol. Cell Physiol. 293 (2007) C738–C748.
[11] W.S. Sly, D. Hewett-Emmett, M.P.Whyte, Y.S. Yu, R.E. Tashian, Carbonic anhydrase II
deﬁciency identiﬁed as the primary defect in the autosomal recessive syndrome of
osteopetrosis with renal tubular acidosis and cerebral calciﬁcation, Proc. Natl.
Acad. Sci. U. S. A. 80 (1983) 2752–2756.
[12] G.N. Shah, B. Ulmasov, A. Waheed, T. Becker, S. Makani, N. Svichar, M. Chesler,
W.S. Sly, Carbonic anhydrase IV and XIV knockout mice: roles of the respective
carbonic anhydrases in buffering the extracellular space in brain, Proc. Natl.
Acad. Sci. U. S. A. 102 (2005) 16771–16776.
[13] N. Svichar, A. Waheed, W.S. Sly, J.C. Hennings, C.A. Hubner, M. Chesler, Carbonic
anhydrases CA4 and CA14 both enhance AE3-mediated Cl−HCO3− exchange in
hippocampal neurons, J. Neurosci. 29 (2009) 3252–3258.
[14] M. Pasternack, S. Smirnov, K. Kaila, Proton modulation of functionally distinct
GABAA receptors in acutely isolated pyramidal neurons of rat hippocampus, Neu-
ropharmacology 35 (1996) 1279–1288.
[15] U. Bonnet, T. Leniger, M. Wiemann, Alteration of intracellular pH and activity of
CA3-pyramidal cells in guinea pig hippocampal slices by inhibition of transmem-
brane acid extrusion, Brain Research 872 (2000) 116–124.
[16] M. Klier, C. Schuler, A.P. Halestrap, W.S. Sly, J.W. Deitmer, H.M. Becker, Transport
activity of the high-afﬁnity monocarboxylate transporter MCT2 is enhanced by
extracellular carbonic anhydrase IV but not by intracellular carbonic anhydrase
II, J. Biol. Chem. 286 (2011) 27781–27791.
[17] Z. Yang, B.V. Alvarez, C. Chakarova, L. Jiang, G. Karan, J.M. Frederick, Y. Zhao, Y.
Sauve, X. Li, E. Zrenner, B.Wissinger, A.I.D. Hollander, B. Katz,W. Baehr, F.P. Cremers,
J.R. Casey, S.S. Bhattacharya, K. Zhang, Mutant carbonic anhydrase 4 impairs pH reg-
ulation and causes retinal photoreceptor degeneration, Hum. Mol. Genet. 14 (2005)
255–265.
[18] J.A. Loncaster, A.L. Harris, S.E. Davidson, J.P. Logue, R.D. Hunter, C.C.Wycoff, J. Pastorek,
P.J. Ratcliffe, I.J. Stratford, C.M. West, Carbonic anhydrase (CA IX) expression, a poten-
tial new intrinsic marker of hypoxia: correlations with tumor oxygen measurements
and prognosis in locally advanced carcinoma of the cervix, Cancer Res. 61 (2001)
6394–6399.
[19] C.C. Wykoff, N.J. Beasley, P.H. Watson, K.J. Turner, J. Pastorek, A. Sibtain, G.D.Wilson,
H. Turley, K.L. Talks, P.H. Maxwell, C.W. Pugh, P.J. Ratcliffe, A.L. Harris, Hypoxia-in-
ducible expression of tumor-associated carbonic anhydrases, Cancer Res. 60
(2000) 7075–7083.
[20] M.H. Bui, D. Seligson, K.R. Han, A.J. Pantuck, F.J. Dorey, Y. Huang, S. Horvath, B.C.
Leibovich, S. Chopra, S.Y. Liao, E. Stanbridge, M.I. Lerman, A. Palotie, R.A. Figlin,
A.S. Belldegrun, Carbonic anhydrase IX is an independent predictor of survival
in advanced renal clear cell carcinoma: implications for prognosis and therapy,
Clin. Cancer Res. 9 (2003) 802–811.
[21] J.R. Turner, R.D. Odze, C.P. Crum, M.B. Resnick, MN antigen expression in normal,
preneoplastic, and neoplastic esophagus: a clinicopathological study of a new
cancer-associated biomarker, Hum. Pathol. 28 (1997) 740–744.
[22] J. Saarnio, S. Parkkila, A.K. Parkkila, K. Haukipuro, S. Pastorekova, J. Pastorek,
M.I. Kairaluoma, T.J. Karttunen, Immunohistochemical study of colorectal tumors
for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with po-
tential value as a marker of cell proliferation, Am. J. Pathol. 153 (1998) 279–285.
[23] Y. Li, H. Wang, E. Oosterwijk, Y. Selman, J.C. Mira, T. Medrano, K.T. Shiverick, S.C.
Frost, Antibody-speciﬁc detection of CAIX in breast and prostate cancers, Biochem.
Biophys. Res. Commun. 386 (2009) 488–492.
[24] J.Y. Winum, A. Scozzafava, J.L. Montero, C.T. Supuran, Inhibition of carbonic anhy-
drase IX: a new strategy against cancer, Anticancer Agents in Medicinal Chemistry
9 (2009) 693–702.
[25] I.P. Kaur, R. Smitha, D. Aggarwal, M. Kapil, Acetazolamide: future perspective in
topical glaucoma therapeutics, Int. J. Pharm. 248 (2002) 1–14.
[26] W.G. Reiss, K.S. Oles, Acetazolamide in the treatment of seizures, Ann. Pharmac-
other. 30 (1996) 514–519.
[27] H.G. Sullivan, T.B.t. Kingsbury, M.E. Morgan, R.D. Jeffcoat, J.D. Allison, J.J. Goode, D.E.
McDonnell, The rCBF response to Diamox in normal subjects and cerebrovascular
disease patients, J. Neurosurg. 67 (1987) 525–534.
[28] C.K. Grissom, R.C. Roach, F.H. Sarnquist, P.H. Hackett, Acetazolamide in the treatment
of acute mountain sickness: clinical efﬁcacy and effect on gas exchange, Ann. Intern.
Med. 116 (1992) 461–465.
[29] M.K. Fasseas, D. Tsikou, E. Flemetakis, P. Katinakis, Molecular and biochemical
analysis of the alpha class carbonic anhydrases in Caenorhabditis elegans, Mol.
Biol. Rep. 38 (2011) 1777–1785.
[30] R.A. Hall, D. Vullo, A. Innocenti, A. Scozzafava, C.T. Supuran, P. Klappa, F.A.
Muhlschlegel, External pH inﬂuences the transcriptional proﬁle of the carbonic
anhydrase, CAH-4b in Caenorhabditis elegans, Mol. Biochem. Parasitol. 161
(2008) 140–149.
[31] T. Bishop, K.W. Lau, A.C. Epstein, S.K. Kim, M. Jiang, D. O'Rourke, C.W. Pugh, J.M.
Gleadle, M.S. Taylor, J. Hodgkin, P.J. Ratcliffe, Genetic analysis of pathways regu-
lated by the von Hippel–Lindau tumor suppressor in Caenorhabditis elegans,
PLoS Biology 2 (2004) e289.
[32] J. Giacomotto, C. Pertl, C. Borrel, M.C. Walter, S. Bulst, B. Johnsen, D.L. Baillie, H.
Lochmuller, C. Thirion, L. Segalat, Evaluation of the therapeutic potential of carbonic
anhydrase inhibitors in two animalmodels of dystrophin deﬁcient muscular dystro-
phy, Hum. Mol. Genet. 18 (2009) 4089–4101.[33] P. Karhumaa, S. Parkkila, A. Waheed, A.K. Parkkila, K. Kaunisto, P.W. Tucker, C.J.
Huang, W.S. Sly, H. Rajaniemi, Nuclear NonO/p54(nrb) protein is a nonclassical
carbonic anhydrase, J. Biol. Chem. 275 (2000) 16044–16049.
[34] C.C. Mello, J.M. Kramer, D. Stinchcomb, V. Ambros, Efﬁcient gene transfer in C. elegans:
extrachromosomal maintenance and integration of transforming sequences, EMBO J.
10 (1991) 3959–3970.
[35] K. Nehrke, A reduction in intestinal cell pHi due to loss of the Caenorhabditis elegans
Na+/H+ exchanger NHX-2 increases life span, J. Biol. Chem. 278 (45) (2003)
44657–44666.
[36] G. Miesenbock, D.A. De Angelis, J.E. Rothman, Visualizing secretion and synaptic
transmission with pH-sensitive green ﬂuorescent proteins, Nature 394 (1998)
192–195.
[37] J.A. Thomas, R.N. Buchsbaum, A. Zimniak, E. Racker, Intracellular pH measurements
in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ, Bio-
chemistry 18 (1979) 2210–2218.
[38] H.P. Hansson, Histochemical demonstration of carbonic anhydrase activity,
Histochemie 11 (1967) 112–128.
[39] N. Fabre, I.M. Reiter, N. Becuwe-Linka, B. Genty, D. Rumeau, Characterization and ex-
pression analysis of genes encoding alpha and beta carbonic anhydrases inArabidopsis,
Plant Cell Environ. 30 (2007) 617–629.
[40] R.E. Tashian, The carbonic anhydrases: widening perspectives on their evolution,
expression and function, Bioessays 10 (1989) 186–192.
[41] S.A. Hazen, A. Waheed, W.S. Sly, K.F. LaNoue, C.J. Lynch, Differentiation-dependent
expression of CA V and the role of carbonic anhydrase isozymes in pyruvate carbox-
ylation in adipocytes, FASEB J. 10 (1996) 481–490.
[42] S.J. Dodgson, Why are there carbonic anhydrases in the liver? Biochem. Cell Biol.
69 (1991) 761–763.
[43] D.J. Culp, B. Robinson, S. Parkkila, P.W. Pan, M.N. Cash, H.N. Truong, T.W. Hussey,
S.L. Gullett, Oral colonization by Streptococcus mutans and caries development is
reduced upon deletion of carbonic anhydrase VI expression in saliva, Biochim.
Biophys. Acta 1812 (2011) 1567–1576.
[44] M. Kimoto, M. Kishino, Y. Yura, Y. Ogawa, A role of salivary carbonic anhydrase VI
in dental plaque, Arch. Oral Biol. 51 (2006) 117–122.
[45] B. Elleby, B. Sjoblom, C. Tu, D.N. Silverman, S. Lindskog, Enhancement of catalytic
efﬁciency by the combination of site-speciﬁc mutations in a carbonic anhydrase-
related protein, Eur. J. Biochem. 267 (2000) 5908–5915.
[46] B. Sjoblom, B. Elleby, K. Wallgren, B.-H. Jonsson, S. Lindskog, Two point mutations
convert a catalytically inactive carbonic anhydrase-related protein (CARP) to an
active enzyme, FEBS Lett. 398 (1996) 322–325.
[47] E. Miyaji, I. Nishimori, K. Taniuchi, T. Takeuchi, Y. Ohtsuki, S. Onishi, Overexpres-
sion of carbonic anhydrase-related protein VIII in human colorectal cancer, J.
Pathol. 201 (2003) 37–45.
[48] Y. Jiao, J. Yan, Y. Zhao, L.R. Donahue, W.G. Beamer, X. Li, B.A. Roe, M.S. Ledoux,
W. Gu, Carbonic anhydrase-related protein VIII deﬁciency is associated with a
distinctive lifelong gait disorder in waddles mice, Genetics 171 (2005)
1239–1246.
[49] M. Hirasawa, X. Xu, R.B. Trask, T.P. Maddatu, B.A. Johnson, J.K. Naggert, P.M. Nishina,
A. Ikeda, Carbonic anhydrase related protein 8 mutation results in aberrant synaptic
morphology and excitatory synaptic function in the cerebellum, Mol. Cell. Neurosci.
35 (2007) 161–170.
[50] J. Hirota, H. Ando, K. Hamada, K. Mikoshiba, Carbonic anhydrase-related protein is
a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1, Biochem.
J. 372 (2003) 435–441.
[51] A.J. Bretscher, E. Kodama-Namba, K.E. Busch, R.J. Murphy, Z. Soltesz, P. Laurent,
M. de Bono, Temperature, oxygen, and salt-sensing neurons in C. elegans are car-
bon dioxide sensors that control avoidance behavior, Neuron 69 (2011)
1099–1113.
[52] P. Swietach, A. Hulikova, R.D. Vaughan-Jones, A.L. Harris, New insights into the
physiological role of carbonic anhydrase IX in tumour pH regulation, Oncogene
29 (2010) 6509–6521.
[53] P.W. Pan, A.K. Parkkila, S. Autio, M. Hilvo, R. Sormunen, S. Pastorekova, J. Pastorek,
H. Haapasalo, S. Parkkila, Brain phenotype of carbonic anhydrase IX-deﬁcient
mice, Transgenic Res. 21 (2012) 163–176.
[54] R. Sultana, M. Perluigi, S.F. Newman, W.M. Pierce, C. Cini, R. Coccia, D.A. Butterﬁeld,
Redox proteomic analysis of carbonylated brain proteins in mild cognitive impair-
ment and early Alzheimer's disease, Antioxid. Redox Signal. 12 (2010) 327–336.
[55] E. Barreiro, S.N. Hussain, Protein carbonylation in skeletal muscles: impact on
function, Antioxid. Redox Signal. 12 (2010) 417–429.
[56] S. Schiffner, N. Zimara, R. Schmid, A.K. Bosserhoff, p54nrb is a new regulator of
progression of malignant melanoma, Carcinogenesis 32 (2011) 1176–1182.
[57] O. Seksek, J. Bolard, Nuclear pH gradient in mammalian cells revealed by laser
microspectroﬂuorimetry, J. Cell Sci. 109 (1996) 257–262.
[58] J. Llopis, J.M. McCaffery, A. Miyawaki, M.G. Farquhar, R.Y. Tsien, Measurement of
cytosolic, mitochondrial, and Golgi pH in single living cells with green ﬂuorescent
proteins, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6803–6808.
[59] S. Papadia, P. Stevenson, N.R. Hardingham, H. Bading, G.E. Hardingham, Nucle-
ar Ca2+ and the cAMP response element-binding protein family mediate a late
phase of activity-dependent neuroprotection, J. Neurosci. 25 (2005)
4279–4287.
[60] S.J. Zhang, M. Zou, L. Lu, D. Lau, D.A. Ditzel, C. Delucinge-Vivier, Y. Aso, P. Descombes,
H. Bading, Nuclear calcium signaling controls expression of a large gene pool: identi-
ﬁcation of a gene program for acquired neuroprotection induced by synaptic activity,
PLoS Genet. 5 (2009) e1000604.
[61] G. Queisser, S. Wiegert, H. Bading, Structural dynamics of the cell nucleus: basis
for morphology modulation of nuclear calcium signaling and gene transcription,
Nucleus 2 (2011) 98–104.
817T.A. Sherman et al. / Biochimica et Biophysica Acta 1823 (2012) 808–817[62] M. Wittmann, G. Queisser, A. Eder, J.S. Wiegert, C.P. Bengtson, A. Hellwig, G.
Wittum, H. Bading, Synaptic activity induces dramatic changes in the geome-
try of the cell nucleus: interplay between nuclear structure, histone H3 phos-
phorylation, and nuclear calcium signaling, J. Neurosci. 29 (2009)
14687–14700.
[63] J. Pfeiffer, D. Johnson, K. Nehrke, Oscillatory transepithelial H(+) ﬂux regulates a
rhythmic behavior in C. elegans, Curr. Biol. 18 (2008) 297–302.[64] M.A. Kader, S. Lindberg, Cytosolic calcium and pH signaling in plants under salinity
stress, Plant Signal. Behav. 5 (2010) 233–238.
[65] A.A. Beg, G.G. Ernstrom, P. Nix, M.W. Davis, E.M. Jorgensen, Protons act as a trans-
mitter for muscle contraction in C. elegans, Cell 132 (2008) 149–160.
[66] M. Sandoval, J. Burgos, F.V. Sepulveda, L.P. Cid, Extracellular pH in restricted domains
as a gating signal for ion channels involved in transepithelial transport, Biol. Pharm.
Bull. 34 (2011) 803–809.
